SureSmile Symposium Unites Global Orthodontic Experts

 Dentsply Sirona is pleased to announce that the SureSmile Global Orthodontics Symposium will take place in London, UK, Sept. 13–14. This premier clinical education event will bring together orthodontic professionals from around the world to exchange knowledge, drive innovation, and elevate patient care. Through interactive sessions, hands-on workshops, and collaborative discussions, participants will gain valuable insights and practical tools to enhance clinical expertise and improve outcomes.

Dentsply Sirona, suresmile symposium

The SureSmile Global Orthodontics Symposium will showcase a diverse lineup of expert speakers covering key topics in digital orthodontics and innovative treatment approaches:

  • Dr. Alex Yusupov – Robotically bent wires for precision and efficiency
  • Dr. Nina Shaffie – Evidence-based approach to managing deep bite with aligners
  • Dr. Josh Rowley – Hybrid treatment solutions to enhance treatment versatility
  • Dr. Cory Costanzo – Digital indirect bonding to improve workflows
  • Dr. Asif Chatoo – Lingual braces with robotically bent wires for unique clinical strategies
  • Dr. Ed Lin – 3D digital orthodontics and robotically bent wires shape dentofacial orthopedics

The event will also offer opportunities to connect with industry leaders and peers, creating meaningful networking and knowledge-sharing experiences.

“The SureSmile Global Orthodontics Symposium is designed to unite the orthodontic community and provide a platform for knowledge exchange and collaboration that leads to better patient outcomes,” said Jill Uhryniak, group vice president, orthodontics and aligner solutions at Dentsply Sirona. “By combining advanced robotic wire manufacturing with expert digital planning, we’re delivering solutions that truly differentiate in the market. We are proud to host an event that not only celebrates innovation but also empowers clinicians to tackle everyday challenges.”

Dr. Nina Shaffie, award-winning specialist orthodontist from London, UK, and event speaker, added: “Being part of a global community that’s committed to sharing knowledge and advancing patient care is both inspiring and empowering. This is an incredible opportunity for orthodontic professionals to come together, learn from one another, and stay at the forefront of our evolving field.”

SureSmile Digital Lab Sessions

Attendees will have the unique opportunity to schedule a 60-minute one-on-one session with a SureSmile digital lab technician. This personalized session allows doctors to explore SureSmile software, review patient-specific treatment considerations, and learn how the digital lab ensures each case meets clinical preferences. During both the speaker sessions and the one-on-one consultations with the digital lab experts, attendees will also have the opportunity to explore SureSmile robotically bent wires.

  • Treatment Times – In a retrospective study, SureSmile Robotically Bent Wires were found to reduce treatment time by 30% compared to conventional approaches.*
  • Office Visits – In a retrospective study, SureSmile Robotically Bent Wires were found to reduce the number of office visits compared to conventional treatment.**
  • Flexible Integration – Compatible with most brackets and suitable for any class or case type.

Register Now!

Registration is still open. Spaces are limited, and participants are encouraged to register by Aug. 31 to secure their place: Registration: 2025 SureSmile Global Orthodontics Symposium

If you’re unable to attend but would like to learn more, please visit For Doctors / Doctor home | SureSmile USA (USA).

For all other regions, visit www.suresmile.com for more information about SureSmile and its solutions.


* This information is based on the data from the cited publication where the average total treatment time was 32.0 months for the conventional group (n = 63) and 22.7 months for the SureSmile group (n = 69), reflecting a 30% reduction in treatment duration, which was statistically significant (p = 0.0001). Individual results may vary depending on the patient or the clinician.

Alford TJ, Roberts WE, Hartsfield Jr JK, Eckert GJ, Snyder RJ. Clinical outcomes for patients finished with the SureSmile™ method compared with conventional fixed orthodontic therapy. The Angle Orthodontist. 2011 May 1;81(3):383–8.

** This information is based on a retrospective analysis of 12,335 patients across 142 practices. The mean office visits were 15 for SureSmile patients (n = 9,390) and 19 for conventional patients (n = 2,945). This difference was statistically significant (p < 0.001). Individual results may vary depending on the patient or the clinician.

Sachdeva RC, Aranha SL, Egan ME, Gross HT, Sachdeva NS, Currier GF, Kadioglu O. Treatment time: SureSmile vs conventional. Orthodontics (Chic.). 2012;13(1):72–85. At the time of the publication, Dr. Rohit C.L. Sachdeva had a financial interest in OraMetrix, which later merged into Dentsply Sirona Orthodontics, Inc., and the second and fifth authors, Dr. Sharan L.T. Aranha and Nikita S. Sachdeva, were employed by OraMetrix.


About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands.

Dentsply Sirona’s innovative products provide high-quality, effective, and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The company’s shares are listed in the United States on Nasdaq under the symbol XRAY.

Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.


DISCLAIMER

This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast,” and similar words and expressions. However, these words are not the exclusive means of identifying such statements.

In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share, and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties, and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the company’s products, the possibility of changing economic, market, and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.

Registered brands, trade names, and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials. Due to the different approval and registration times, not all technologies and products are immediately available in all countries. Please reach out to a local dealer or sales representative for more information.

Comments